title: Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study.
abstract: A pilot study was performed to determine the effect of 40,000 IU Epo on myocardial damage in 51 patients with non-ST segment elevation acute coronary syndrome (non-STE ACS). No significant difference in myocardial damage was found, but an increased systolic blood pressure was noticed.
authors.affiliation: Oosterschelde Ziekenhuizen, Goes, The Netherlands. anho@zeelandnet.nl
authors.forename: Anho
authors.initials: A
authors.lastname: Liem
authors.forename: Anton P
authors.initials: AP
authors.lastname: van de Woestijne
authors.forename: Erik
authors.initials: E
authors.lastname: Bruijns
authors.forename: Henk W O
authors.initials: HW
authors.lastname: Roeters van Lennep
authors.forename: Job A J
authors.initials: JA
authors.lastname: de Boo
authors.forename: Henk K
authors.initials: HK
authors.lastname: van Halteren
authors.forename: Teun P
authors.initials: TP
authors.lastname: van Es
authors.forename: J Wouter
authors.initials: JW
authors.lastname: Jukema
authors.forename: Arnoud
authors.initials: A
authors.lastname: van der Laarse
authors.forename: Aeilko H
authors.initials: AH
authors.lastname: Zwinderman
authors.forename: Dirk J
authors.initials: DJ
authors.lastname: van Veldhuisen
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000473:pathology*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000473:pathology; D010865:Pilot Projects; D011446:Prospective Studies; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa